List of Excipients in API terbinafine hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing terbinafine hydrochloride
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Haleon US Holdings LLC | LAMISIL | terbinafine hydrochloride | 0067-3998 | BENZYL ALCOHOL | |
| Haleon US Holdings LLC | LAMISIL | terbinafine hydrochloride | 0067-3998 | CETYL ALCOHOL | |
| Haleon US Holdings LLC | LAMISIL | terbinafine hydrochloride | 0067-3998 | CETYL PALMITATE | |
| Haleon US Holdings LLC | LAMISIL | terbinafine hydrochloride | 0067-3998 | ISOPROPYL MYRISTATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing terbinafine hydrochloride
Detailed excipient profiles for terbinafine hydrochloride
Excipient focus: ALCOHOL
terbinafine hydrochloride drug variants containing ALCOHOL
terbinafine hydrochloride drug variants not containing ALCOHOL
Excipient focus: BENZYL ALCOHOL
terbinafine hydrochloride drug variants containing BENZYL ALCOHOL
terbinafine hydrochloride drug variants not containing BENZYL ALCOHOL
Excipient focus: CELLULOSE, MICROCRYSTALLINE
terbinafine hydrochloride drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Northstar Rx LLC | terbinafine hydrochloride | 16714-501 |
| NorthStar Rx LLC | terbinafine hydrochloride | 16714-795 |
| Rebel Distributors Corp | terbinafine hydrochloride | 21695-630 |
| OrchidPharma Inc | terbinafine hydrochloride | 42043-410 |
| >Company | >Ingredient | >NDC |
terbinafine hydrochloride drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CETYL ALCOHOL
terbinafine hydrochloride drug variants containing CETYL ALCOHOL
terbinafine hydrochloride drug variants not containing CETYL ALCOHOL
Excipient focus: CETYL PALMITATE
terbinafine hydrochloride drug variants containing CETYL PALMITATE
terbinafine hydrochloride drug variants not containing CETYL PALMITATE
Excipient focus: CROSCARMELLOSE SODIUM
terbinafine hydrochloride drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | terbinafine hydrochloride | 54868-5794 |
| DrReddys Laboratories Limited | terbinafine hydrochloride | 55111-250 |
| >Company | >Ingredient | >NDC |
terbinafine hydrochloride drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: FERRIC OXIDE RED
terbinafine hydrochloride drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Northstar Rx LLC | terbinafine hydrochloride | 16714-501 |
| OrchidPharma Inc | terbinafine hydrochloride | 42043-410 |
| A-S Medication Solutions | terbinafine hydrochloride | 50090-7300 |
| NuCare PharmaceuticalsInc | terbinafine hydrochloride | 68071-2426 |
| >Company | >Ingredient | >NDC |
terbinafine hydrochloride drug variants not containing FERRIC OXIDE RED
Excipient focus: HYPROMELLOSE
terbinafine hydrochloride drug variants containing HYPROMELLOSE
terbinafine hydrochloride drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
terbinafine hydrochloride drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Northstar Rx LLC | terbinafine hydrochloride | 16714-501 |
| NorthStar Rx LLC | terbinafine hydrochloride | 16714-795 |
| OrchidPharma Inc | terbinafine hydrochloride | 42043-410 |
| PD-Rx Pharmaceuticals Inc | terbinafine hydrochloride | 43063-598 |
| >Company | >Ingredient | >NDC |
terbinafine hydrochloride drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
terbinafine hydrochloride drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | terbinafine hydrochloride | 21695-630 |
| DrReddys Laboratories Limited | terbinafine hydrochloride | 55111-250 |
| >Company | >Ingredient | >NDC |
terbinafine hydrochloride drug variants not containing HYPROMELLOSES
Excipient focus: ISOPROPYL MYRISTATE
terbinafine hydrochloride drug variants containing ISOPROPYL MYRISTATE
terbinafine hydrochloride drug variants not containing ISOPROPYL MYRISTATE
Excipient focus: MAGNESIUM STEARATE
terbinafine hydrochloride drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Northstar Rx LLC | terbinafine hydrochloride | 16714-501 |
| NorthStar Rx LLC | terbinafine hydrochloride | 16714-795 |
| Rebel Distributors Corp | terbinafine hydrochloride | 21695-630 |
| OrchidPharma Inc | terbinafine hydrochloride | 42043-410 |
| >Company | >Ingredient | >NDC |
terbinafine hydrochloride drug variants not containing MAGNESIUM STEARATE
Excipient focus: METHYLCELLULOSE
terbinafine hydrochloride drug variants containing METHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | terbinafine hydrochloride | 54868-5794 |
| >Company | >Ingredient | >NDC |
terbinafine hydrochloride drug variants not containing METHYLCELLULOSE
Excipient focus: POLYOXYL 20 CETOSTEARYL ETHER
terbinafine hydrochloride drug variants containing POLYOXYL 20 CETOSTEARYL ETHER
terbinafine hydrochloride drug variants not containing POLYOXYL 20 CETOSTEARYL ETHER
Excipient focus: POLYSORBATE 60
terbinafine hydrochloride drug variants containing POLYSORBATE 60
terbinafine hydrochloride drug variants not containing POLYSORBATE 60
Excipient focus: PROPYLENE GLYCOL
terbinafine hydrochloride drug variants containing PROPYLENE GLYCOL
terbinafine hydrochloride drug variants not containing PROPYLENE GLYCOL
Excipient focus: SILICON DIOXIDE
terbinafine hydrochloride drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Northstar Rx LLC | terbinafine hydrochloride | 16714-501 |
| NorthStar Rx LLC | terbinafine hydrochloride | 16714-795 |
| Rebel Distributors Corp | terbinafine hydrochloride | 21695-630 |
| OrchidPharma Inc | terbinafine hydrochloride | 42043-410 |
| >Company | >Ingredient | >NDC |
terbinafine hydrochloride drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM HYDROXIDE
terbinafine hydrochloride drug variants containing SODIUM HYDROXIDE
terbinafine hydrochloride drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
terbinafine hydrochloride drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Northstar Rx LLC | terbinafine hydrochloride | 16714-501 |
| NorthStar Rx LLC | terbinafine hydrochloride | 16714-795 |
| Rebel Distributors Corp | terbinafine hydrochloride | 21695-630 |
| OrchidPharma Inc | terbinafine hydrochloride | 42043-410 |
| >Company | >Ingredient | >NDC |
terbinafine hydrochloride drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: SORBITAN MONOSTEARATE
terbinafine hydrochloride drug variants containing SORBITAN MONOSTEARATE
terbinafine hydrochloride drug variants not containing SORBITAN MONOSTEARATE
Excipient focus: STEARYL ALCOHOL
terbinafine hydrochloride drug variants containing STEARYL ALCOHOL
terbinafine hydrochloride drug variants not containing STEARYL ALCOHOL
Excipient focus: WATER
terbinafine hydrochloride drug variants containing WATER
terbinafine hydrochloride drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Northstar Rx LLC | terbinafine hydrochloride | 16714-501 |
| NorthStar Rx LLC | terbinafine hydrochloride | 16714-795 |
| Rebel Distributors Corp | terbinafine hydrochloride | 21695-630 |
| OrchidPharma Inc | terbinafine hydrochloride | 42043-410 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
